WMA
ABBV icon

Wealth Management Associates’s AbbVie ABBV Stock Holding History

Wealth Management Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
6,759
+253
+4% +$54.4K 0.47% 46
2026
Q1 		$1.41M Buy
6,506
+5
+0.1% +$1.11K 0.49% 47
2025
Q4 		$1.49M Buy
6,501
+5
+0.1% +$1.14K 0.52% 44
2025
Q3 		$1.5M Buy
6,496
+5
+0.1% +$1.02K 0.53% 44
2025
Q2 		$1.2M Sell
6,491
-528
-8% -$98.1K 0.47% 47
2025
Q1 		$1.47M Buy
7,019
+6
+0.1% +$1.17K 0.63% 38
2024
Q4 		$1.25M Buy
7,013
+91
+1% +$16.7K 0.53% 43
2024
Q3 		$1.37M Buy
6,922
+5
+0.1% +$933 0.6% 39
2024
Q2 		$1.19M Hold
6,917
– – 0.56% 41
2024
Q1 		$1.19M Sell
6,917
-353
-5% -$60.8K 0.56% 41
2023
Q4 		$1.13M Sell
7,270
-370
-5% -$53.9K 0.59% 42
2023
Q3 		$1.14M Sell
7,640
-421
-5% -$61.8K 0.67% 36
2023
Q2 		$1.09M Sell
8,061
-30
-0.4% -$4.4K 0.62% 37
2023
Q1 		$1.29M Sell
8,091
-66
-0.8% -$10.1K 0.8% 27
2022
Q4 		$1.32M Sell
8,157
-1,150
-12% -$176K 0.88% 26
2022
Q3 		$1.25M Buy
9,307
+9
+0.1% +$1.29K 0.88% 25
2022
Q2 		$1.42M Buy
9,298
+2,866
+45% +$438K 0.97% 22
2022
Q1 		$1.04M Buy
6,432
+424
+7% +$61.6K 0.59% 39
2021
Q4 		$814K Buy
6,008
+1,003
+20% +$118K 0.44% 55
2021
Q3 		$540K Buy
5,005
+1,340
+37% +$153K 0.32% 80
2021
Q2 		$413K Buy
3,665
+35
+1% +$3.94K 0.23% 115
2021
Q1 		$393K Buy
3,630
+293
+9% +$31.3K 0.25% 105
2020
Q4 		$358K Sell
3,337
-22
-0.7% -$2.11K 0.23% 108
2020
Q3 		$294K Buy
3,359
+94
+3% +$8.85K 0.23% 111
2020
Q2 		$321K Buy
3,265
+483
+17% +$42.5K 0.27% 89
2020
Q1 		$212K Sell
2,782
-97
-3% -$8.26K 0.21% 104
2019
Q4 		$255K Buy
+2,879
New +$239K 0.18% 124
2019
Q1 		– Sell
-2,472
Closed -$228K – 94
2018
Q4 		$228K Buy
+2,472
New +$217K 0.31% 76

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Management Associates's ABBV Position: Q2 2026 in Review

Wealth Management Associates increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $54.4K and bringing the position to 6,759 shares worth $1.7M. The position accounts for 0.47% of the portfolio, ranked #46.

Wealth Management Associates first reported a position in ABBV in Q4 2018 and has held it in 28 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Management Associates held 6,759 shares of AbbVie worth $1.7M as of Q2 2026.
  • Wealth Management Associates bought 253 AbbVie shares in Q2 2026, an estimated $54.4K.
  • AbbVie made up 0.47% of Wealth Management Associates's portfolio in Q2 2026, its #46 holding.
  • Wealth Management Associates first reported a position in AbbVie in Q4 2018 and has held it in 28 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Management Associates's 13F filing for Q2 2026, filed 21 Jul 2026.